Glukem Pharmaceuticals Pvt. Ltd

Cherlapally, India

Glukem Pharmaceuticals Pvt. Ltd

Cherlapally, India
SEARCH FILTERS
Time filter
Source Type

Reddy A.B.,Glukem pharmaceuticals Pvt ltd
International Journal of Drug Development and Research | Year: 2011

The purpose of the present study was to develop an optimized gastric floating drug delivery system (GFDDS) containing Aceclofenac as a model drug by using various proportion of polymers such as HPMC E5M and Eudragit RS 100. This was employed to enhance the bioavailability and therapeutic efficacy of the drug. The sustained release formulations of aceclofenac using hydrophobic and hydrophilic polymers were prepared by direct compression method. Optimization of formulation was done by studying effect of drug to polymer ratio on drug release. FT- IR studies indicated absence of any interaction between aceclofenac, polymer (Eudragit RS 100, HPMCE5M) and excipients. Five formulations were prepared and formulation A5 possessed good floating property with total floating time between 8-10 hours. The tablets were also evaluated for its hardness, friability and other In-vitro evaluation tests. All parameters complied with IP limits. Results of this study indicated that the combinations of hydrophilic polymers with hydrophobic polymers are suitable to optimize sustained release formulation of aceclofenac. © 2010 IJDDR.


Burugula L.,Jawaharlal Nehru University | Mullangi R.,Jubliant Biosys | Pilli N.R.,Jawaharlal Nehru University | Makula A.,Jawaharlal Nehru University | And 2 more authors.
Biomedical Chromatography | Year: 2013

A simple, rapid and sensitive liquid chromatography-tandem mass spectrometric (LC-MS/MS) assay method has been developed and validated for simultaneous quantification of sitagliptin and simvastatin in human plasma. Carbamazepine was used as an internal standard (IS). The analytes and IS were extracted from the human plasma by liquid-liquid extraction technique. The reconstituted samples were chromatographed on an Alltima HP C18 column using an isocratic solvent mixture [acetonitrile-5mm ammonium acetate (pH 4.5), 85:15 (v/v)] at a flow rate of 1.0mL/min. Method validation was performed as per Food and Drug Administration guidelines and the results met the acceptance criteria. The calibration curves obtained were linear (r2≥0.99) over the concentration range of 0.10-501 and 0.05-105ng/mL for sitagliptin and simvastatin, respectively. The results of the intra- and inter-day precision and accuracy studies were well within the acceptable limits. Both the analytes were found to be stable in a battery of stability studies. The method is precise and sensitive enough for its intended purpose. A run time of 3.0min for each sample made it possible to analyze more than 300 plasma samples per day. The developed assay was successfully applied to a pharmacokinetic study in human volunteers. © 2012 John Wiley & Sons, Ltd.


Burugula L.,Glukem Pharmaceuticals Pvt. Ltd | Pilli N.R.,Glukem Pharmaceuticals Pvt. Ltd | Makula A.,Glukem Pharmaceuticals Pvt. Ltd | Lodagala D.S.,Jawaharlal Nehru University | Kandhagatla R.,Bristl Laboratories Ltd
Biomedical Chromatography | Year: 2013

An analytical method based on liquid chromatographic-tandem mass spectrometry (LC-MS/MS) was developed for the determination of the non-nucleoside reverse transcriptase inhibitor rilpivirine in human plasma using nevirapine as an internal standard. Analyte and the internal standard were extracted from human plasma by liquid-liquid extraction. The reconstituted samples were chromatographed on a C18 column using a mixture of acetonitrile and 0.1% formic acid buffer (80:20, v/v) as the mobile phase at a flow rate of 0.5mL/min. The linearity was confirmed in the concentration range 0.51-200ng/mL in human plasma. Multiple reaction monitoring mode was used for quantification of ion transitions at m/z 367.2/195.1 and 267.1/226.1 for the drug and the internal standard, respectively. The results of the intra- and inter-day precision and accuracy studies were well within the acceptable limits. Extraction recoveries of drug from plasma were >69.5%. A run time of 2.50min for each sample made it possible to analyze more than 300 plasma samples per day. The developed method is simple, rapid and sensitive for the determination of rilpivirine concentrations in real-time plasma samples obtained from pharmacokinetic studies. © 2012 John Wiley & Sons, Ltd.

Loading Glukem Pharmaceuticals Pvt. Ltd collaborators
Loading Glukem Pharmaceuticals Pvt. Ltd collaborators